Prognostic Value of Bone Formation and Resorption Proteins in Heterotopic Ossification in Critically-Ill Patients. A Single-Centre Study

1Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476-86. Potter BK Burns TC Lacap AP Granville RR Gajewski DA Heterotopic ossification following traumatic and combat-related amputations Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am 200789476 8610.2106/JBJS.F.0041217332095Search in Google Scholar

2Sanchez-Duffhues G, Hiepen C, Knaus P, Ten Dijke P. Bone morphogenetic protein signalling in bone homeostasis. Bone 2015;80:43-59. Sanchez-Duffhues G Hiepen C Knaus P Ten Dijke P Bone morphogenetic protein signalling in bone homeostasis Bone 20158043 5910.1016/j.bone.2015.05.02526051467Search in Google Scholar

3Grafe I, Alexander S, Peterson JR, et al. TGF-beta Family Signaling in Mesenchymal Differentiation. Cold Spring Harb Perspect Biol. 2018;10: a022202. Grafe I Alexander S Peterson JR et al TGF-beta Family Signaling in Mesenchymal Differentiation Cold Spring Harb Perspect Biol 201810 a02220210.1101/cshperspect.a022202593259028507020Search in Google Scholar

4Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009;18:545-59. Kang Q Song WX Luo Q et al A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells Stem Cells Dev 200918545 5910.1089/scd.2008.0130313295018616389Search in Google Scholar

5Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007;25:665-77. Luu HH Song WX Luo X et al Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells J Orthop Res 200725665 7710.1002/jor.2035917290432Search in Google Scholar

6Wang YK, Sun WF, Liu XG, et al. Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients. Zhongguo Gu Shang. 2011;24:399-403. Wang YK Sun WF Liu XG et al Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients Zhongguo Gu Shang 201124399 403Search in Google Scholar

7Kang H, Dang AB, Joshi SK, et al. Novel mouse model of spinal cord injury-induced heterotopic ossification. J Rehabil Res Dev. 2014;51:1109-18. Kang H Dang AB Joshi SK et al Novel mouse model of spinal cord injury-induced heterotopic ossification J Rehabil Res Dev 2014511109 1810.1682/JRRD.2014.01.001925436890Search in Google Scholar

8Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004;292:490-5. Hofbauer LC Schoppet M Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases JAMA 2004292490 510.1001/jama.292.4.49015280347Search in Google Scholar

9Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modelling and remodelling. Arch Biochem Biophys. 2008;473:139-46. Boyce BF Xing L Functions of RANKL/RANK/OPG in bone modelling and remodelling Arch Biochem Biophys 2008473139 4610.1016/j.abb.2008.03.018241341818395508Search in Google Scholar

10Boyce BF, Xing L, Shakespeare W, et al. Regulation of bone remodelling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases. Kidney Int Suppl. 2003:S2-5. Boyce BF Xing L Shakespeare W et al Regulation of bone remodelling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases Kidney Int Suppl 2003S2–510.1046/j.1523-1755.63.s85.2.x12753255Search in Google Scholar

11Sherman AL, Williams J, Patrick L, Banovac K. The value of serum creatine kinase in early diagnosis of heterotopic ossification. J Spinal Cord Med. 2003;26:227-30. Sherman AL Williams J Patrick L Banovac K The value of serum creatine kinase in early diagnosis of heterotopic ossification J Spinal Cord Med 200326227 3010.1080/10790268.2003.1175368814997963Search in Google Scholar

12Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10. Singer M Deutschman CS Seymour CW et al The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016315801 1010.1001/jama.2016.0287Search in Google Scholar

13Argyropoulou MI, Kostandi E, Kosta P, et al. Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging. Crit Care, 2006;10:R152. Argyropoulou MI Kostandi E Kosta P et al Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging Crit Care 200610R15210.1186/cc5083Search in Google Scholar

14Yano M, Kawao N, Okumoto K, Tamura Y, Okada K, Kaji H. Fibrodysplasia ossificans progressiva-related activated activin-like kinase signalling enhances osteoclast formation during heterotopic ossification in muscle tissues. J Biol Chem. 2014;289:16966-77. Yano M Kawao N Okumoto K Tamura Y Okada K Kaji H Fibrodysplasia ossificans progressiva-related activated activin-like kinase signalling enhances osteoclast formation during heterotopic ossification in muscle tissues J Biol Chem 201428916966 7710.1074/jbc.M113.526038Search in Google Scholar

15Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009;91:652-63. Lounev VY Ramachandran R Wosczyna MN Yamamoto M Maidment AD Shore EM et al Identification of progenitor cells that contribute to heterotopic skeletogenesis J Bone Joint Surg Am 200991652 6310.2106/JBJS.H.01177Search in Google Scholar

16Scott MA, Levi B, Askarinam A, et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012;21:655-67. Scott MA Levi B Askarinam A et al Brief review of models of ectopic bone formation Stem Cells Dev 201221655 6710.1089/scd.2011.0517Search in Google Scholar

17Tanaka H, Nagai E, Murata H, et al. Involvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament. Rheumatology 2001;40:1163-8. Tanaka H Nagai E Murata H et al Involvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament Rheumatology 2001401163 810.1093/rheumatology/40.10.1163Search in Google Scholar

18Suzuki T, Bessho K, Segami N, Nojima T, Iizuka T. Bone morphogenetic protein-2 in temporomandibular joints with internal derangement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:670-3. Suzuki T Bessho K Segami N Nojima T Iizuka T Bone morphogenetic protein-2 in temporomandibular joints with internal derangement Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199988670 310.1016/S1079-2104(99)70007-7Search in Google Scholar

19Zhou N, Li Q, Lin X, et al. BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell Tissue Res. 2016;366:101-11. Zhou N Li Q Lin X et al BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells Cell Tissue Res 2016366101 1110.1007/s00441-016-2403-027083447Search in Google Scholar

20Qu X, Chen Z, Fan D, Xiang S, Sun C, Zeng Y, et al. Two novel BMP-2 variants identified in patients with thoracic ossification of the ligamentum flavum. Eur J Hum Genet 2017;25:565-571. Qu X Chen Z Fan D Xiang S Sun C Zeng Y et al Two novel BMP-2 variants identified in patients with thoracic ossification of the ligamentum flavum Eur J Hum Genet 201725565 57110.1038/ejhg.2017.2543790728145426Search in Google Scholar

21Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008;14:1363-9. Yu PB Deng DY Lai CS et al BMP type I receptor inhibition reduces heterotopic [corrected] ossification Nat Med 2008141363 910.1038/nm.1888284645819029982Search in Google Scholar

22Micha D, Voermans E, Eekhoff MEW, et al. Inhibition of TGFbeta signalling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease. Bone 2016;84:169-180. Micha D Voermans E Eekhoff MEW et al Inhibition of TGFbeta signalling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease Bone 201684169 18010.1016/j.bone.2016.01.004Search in Google Scholar

23Agarwal S, Loder SJ, Breuler C, et al. Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification. Mol Ther. 2017;25:1974-1987. Agarwal S Loder SJ Breuler C et al Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification Mol Ther 2017251974 198710.1016/j.ymthe.2017.01.008Search in Google Scholar

24Wu J, Ren B, Shi F, Hua P, Lin H. BMP and mTOR signalling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities? J Cell Biochem. 2019;120:12108-12122. Wu J Ren B Shi F Hua P Lin H BMP and mTOR signalling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities? J Cell Biochem 201912012108 1212210.1002/jcb.28710Search in Google Scholar

25Al-Fakhri N, Hofbauer LC, Preissner KT, Franke FE, Schoppet M. Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. Thromb Haemost. 2005;94:1335-7. Al-Fakhri N Hofbauer LC Preissner KT Franke FE Schoppet M Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification Thromb Haemost 2005941335 710.1160/TH05-06-1335Search in Google Scholar

26Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12(9):1260-8. Bucay N Sarosi I Dunstan CR et al Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 19981291260 810.1101/gad.12.9.1260Search in Google Scholar

27Wilkinson JM, Stockley I, Hamer AJ, Barrington NA, Eastell R. Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res. 2003;21:529-34. Wilkinson JM Stockley I Hamer AJ Barrington NA Eastell R Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty J Orthop Res 200321529 3410.1016/S0736-0266(02)00236-XSearch in Google Scholar

28Hudson SJ, Brett SJ. Heterotopic ossification--a long-term consequence of prolonged immobility. Crit Care, 2006;10:174. Hudson SJ Brett SJ Heterotopic ossification--a long-term consequence of prolonged immobility Crit Care 20061017410.1186/cc5091Search in Google Scholar

29Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908-923. Eastell R Szulc P Use of bone turnover markers in postmenopausal osteoporosis Lancet Diabetes Endocrinol 20175908 92310.1016/S2213-8587(17)30184-5Search in Google Scholar

30Fatayerji D, Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res. 1999;14:1203-10. Fatayerji D Eastell R Age-related changes in bone turnover in men J Bone Miner Res 1999141203 1010.1359/jbmr.1999.14.7.120310404022Search in Google Scholar